..., instructions or products referred to in the content or advertisements. 2024 Leucine-rich α-2 glycoprotein 1 Kidney disease Diabetic nephropathy Kidney injury Biomarker Transforming growth factor β Kidney diseases, which encompass acute kidney injury (AKI) and chronic kidney diseases (CKDs...

... mortality, indicating an urgent need to further explore the underlying pathogenesis and potential biomarkers. Exosomes are nanoscale vesicles secreted by all cell types that play an essential role in cellular homeostasis and intercellular communications by transferring molecular cargoes between different...

... Biomarker Therapeutics National Institutes of Health (NIH) 10.13039/100000002 Over the last decade, the concept of kidney inflammation by circulating mediators has centered on soluble urokinase-type plasminogen activator receptor (suPAR), an innate immune effector molecule...

.... Low plasma ADMA may help to predict complete remission in proliferative LN patients treated with cyclophosphamide as induction therapy. Plasma ADMA may be a new biomarker to determine the pathological type of LN and predict the therapeutic effect. The ADMA levels of all of the participants were...

...Jun Shiota Background: Although presepsin (P-SEP) is an early sepsis biomarker, sepsis is often suspected after starting hemodialysis (HD). To enhance the utility of P-SEP, we investigated whether pre-HD P-SEP levels could be predicted using the P-SEP levels from blood samples collected after...

..., Hocher B: Biomarkers for the prediction of mortality and morbidity in patients with renal replacement therapy. Clin Lab 2011;57:455-467. 54. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease...

... significant correlation with the peak serum creatinine level, duration of hospital stay, and probably the need for temporary dialysis. Our result suggests that urinary mtDNA has the potential to serve as a biomarker of AKI. ccszeto@cuhk.edu.hk 29 11 2016 19 04 2017 17 5 2017...

... by a rise in serum FGF23 at an early stage of chronic kidney disease (CKD) functions as an early biomarker for kidney dysfunction and can also serve as a predictor for risk of cardiovascular disease (CVD) and mortality in both CKD patients and the general population. Moreover, Klotho deficiency...

... the diagnostic and prognostic predictive power of these biomarkers with reference to acute CRS. Although more research is needed, the current results are very promising. Acute cardiorenal syndrome Acute kidney injury Angiotensinogen Biomarker Prediction ffhouguangzhou@163.com 28 07 2016...